A GLP-1/glucagon dual agonist induced significant weight loss and improved multiple cardiometabolic parameters for adults ...

As Pfizer acquires MET-097 maker Metsera, phase 2 data show potential for greater tolerability and once-monthly dosing.

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

This is read by an automated voice. Please report any issues or inconsistencies here. If you’ve injected your weight-loss medication in an airport bathroom, you’re not alone. Or maybe you decided to ...

Share on Pinterest The “golden dose” left in Mounjaro or Ozempic pens may do more harm than good, according to experts. Design by MNT; Photography by Bloomberg/Getty Images Over the last few years, ...

“In general, we tend to see more weight loss with GLP-1-based medication treatment in patients who are female, those who do ...

BEIJING, Sept. 18, 2025 /PRNewswire/ -- Beijing QL Biopharmaceutical Co., Ltd. (hereafter "QL Biopharm" or the "company") announced today at the European Association for the Study of Diabetes (EASD) ...

Eli Lilly’s oral GLP-1, orforglipron, led to significant weight loss and blood sugar reductions in a late-stage clinical trial. In the phase 3 study, adults with obesity, were overweight and with Type ...

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Andy Cohen is admitting to dabbling in the world of weight loss drugs. The "Real Housewives" executive producer opened up about "micro-dosing" on an unnamed GLP-1 weight loss drug on his SiriusXM ...